Lithocholic acid downregulates vitamin D effects in human osteoblasts

European Journal of Clinical Investigation

Volumn 40, Issue 1, 2010, Pages 25-34

  Ruiz Gaspa S ^a,b   Guanabens N ^a,b   Enjuanes, A ^b   Peris, P ^a,b   Martinez Ferrer, A ^a,b   Martinez De Osaba, M J ^a,b   Gonzalez, B ^a,b   Alvarez, L ^a,b   Monegal, A ^a,b   Combalia, A ^b   Pares A ^a,b,c  

^a INSTITUTO DE SALUD CARLOS III   (Spain)

^b Department of Rheumatology   (Spain)

^c UNIVERSITY OF BARCELONA   (Spain)

Author keywords

Bile acids; Cholestasis; Osteoblasts; Osteoporosis; Vitamin D

Indexed keywords

CYTOCHROME P450; CYTOCHROME P450 24A; LITHOCHOLIC ACID; OSTEOCALCIN; OSTEOCLAST DIFFERENTIATION FACTOR; UNCLASSIFIED DRUG; VITAMIN D; VITAMIN D RECEPTOR;

ARTICLE; BONE MINERAL; CELL CULTURE; CELL FUNCTION; CELL MATURATION; CELL SURVIVAL; CELL VIABILITY; DOWN REGULATION; GENETIC TRANSFECTION; HOMEOSTASIS; HUMAN; HUMAN CELL; OSTEOBLAST; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN EXPRESSION; REPORTER GENE; VITAMIN D METABOLISM;

CELL SURVIVAL; CELLS, CULTURED; CHOLESTASIS; DOWN-REGULATION; HUMANS; LITHOCHOLIC ACID; OSTEOBLASTS; OSTEOCALCIN; OSTEOPOROSIS; OSTEOPROTEGERIN; PROMOTER REGIONS, GENETIC; RANK LIGAND; RNA; STEROID HYDROXYLASES; TRANSFECTION; VITAMIN D;

EID: 74049093659     PISSN: 00142972     EISSN: 13652362     Source Type: Journal    
DOI: 10.1111/j.1365-2362.2009.02230.x     Document Type: Article

References (46)

1. Menon KV, Angulo P, Weston S, Dickson ER, Lindor KD. Bone disease in primary biliary cirrhosis: independent indicators and rate of progression. J Hepatol 2001 35 : 316 323.
2. Guañabens N, Parés A, Mariñoso L, Brancós MA, Piera C, Serrano S et al. Factors influencing the development of metabolic bone disease in primary biliary cirrhosis. Am J Gastroenterol 1990 85 : 1356 1362.
3. Leidig-Bruckner G, Hosch S, Dodidou P, Ritschel D, Conradt C, Klose C et al. Frequency and predictors of osteoporotic fractures after cardiac or liver transplantation: a follow-up study. Lancet 2001 357 : 342 347.
4. Hodgson SF, Dickson ER, Wahner HW, Johnson KA, Mann KG, Riggs BL. Bone loss and reduced osteoblast function in primary biliary cirrhosis. Ann Intern Med 1985 103 : 855 860.
5. Eastell R, Dickson ER, Hodgson SF, Wiesner RH, Porayko MK, Wahner HW et al. Rates of vertebral bone loss before and after liver transplantation in women with primary biliary cirrhosis. Hepatology 1991 14 : 296 300.
6. Guichelaar MM, Kendall R, Malinchoc M, Hay JE. Bone mineral density before and after OLT; long-term follow-up and predictive factors. Liver Transpl 2006 12 : 1390 1402.
7. Janes CH, Dickson ER, Okazaki R, Bonde S, McDonagh AF, Riggs BL. Role of hyperbilirubinemia in the impairment of osteoblast proliferation associated with cholestatic jaundice. J Clin Invest 1995 95 : 2581 2586.
8. DeLuca HF. Discovery of the vitamin D endocrine system. J Nutr 1997 127 : 1050S 2S.
9. Sutton AL, MacDonald PN. Vitamin D: more than a "bone-a-fide" hormone. Mol Endocrinol 2003 17 : 777 791.
10. Haussler MR, Mangelsdorf DJ, Komm BS, Terpening CM, Yamaoka K, Allegretto EA et al. Molecular biology of the vitamin D hormone. Recent Prog Horm Res 1988 44 : 263 305.
11. van Leeuwen JP, van Driel M, van den Bemd GJ, Pols HA. Vitamin D control of osteoblast function and bone extracellular matrix mineralization. Crit Rev Eukaryot Gene Expr 2001 11 : 199 226.
12. McDonnell DP, Mangelsdorf DJ, Pike JW, Haussler MR, O'Malley BW. Molecular cloning of complementary DNA encoding the avian receptor for vitamin D. Science 1987 235 : 1214 1217.
13. Baker AR, McDonnell DP, Hughes M, Crisp TM, Mangelsdorf DJ, Haussler MR et al. Cloning and expression of full-length cDNA encoding human vitamin D receptor. Proc Natl Acad Sci USA 1988 85 : 3294 3298.
14. Jurutka PW, Whitfield GK, Hsieh JC, Thompson PD, Haussler CA, Haussler MR. Molecular nature of the vitamin D receptor and its role in regulation of gene expression. Rev Endocr Metab Disord 2001 2 : 203 216.
15. Ozono K, Liao J, Kerner SA, Scott RA, Pike JW. The vitamin D-responsive element in the human osteocalcin gene, Association with a nuclear proto-oncogene enhancer. J Biol Chem 1990 265 : 21881 21888.
16. Christakos S. Vitamin D gene regulation. In : Bilezikian JP, Raisz LG, Rodan GA, editors. Principles of Bone Biology. San Diego, CA : Academic Press, 2002 : 573 586.
17. Shen Q, Christakos S. The vitamin D receptor, Runx2, and the Notch signaling pathway cooperate in the transcriptional regulation of osteopontin. J Biol Chem 2005 280 : 40589 40598.
18. Kitazawa R, Mori K, Yamaguchi A, Kondo T, Kitazawa S. Modulation of mouse RANKL gene expression by Runx2 and vitamin D3. J Cell Biochem 2008 105 : 1289 1297.
19. 3 is mediated through multiple long-range enhancers. Mol Cell Biol 2006 26 : 6469 6486.
20. Makishima M, Lu TT, Xie W, Whitfield GK, Domoto H, Evans RM et al. Vitamin D receptor as an intestinal bile acid sensor. Science 2002 296 : 1313 1316.
21. Chiang JY. Bile acid regulation of hepatic physiology: III. Bile acids and nuclear receptors. Am J Physiol Gastrointest Liver Physiol 2003 284 : G349 56.
22. Adachi R, Honma Y, Masuno H, Kawana K, Shimomura I, Yamada S et al. Selective activation of vitamin D receptor by lithocholic acid acetate, a bile acid derivative. J Lipid Res 2005 46 : 46 57.
23. Ishizawa M, Matsunawa M, Adachi R, Uno S, Ikeda K, Masuno H et al. Lithocholic acid derivatives act as selective vitamin D receptor modulators without inducing hypercalcemia. J Lipid Res 2008 49 : 763 772.
24. Fischer S, Beuers U, Spengler U, Zwiebel FM, Koebe HG. Hepatic levels of bile acids in end-stage chronic cholestatic liver disease. Clin Chim Acta 1996 251 : 173 186.
25. Castaño G, Lucangioli S, Sookoian S, Mesquida M, Lemberg A, Di Scala M et al. Bile acid profiles by capillary electrophoresis in intrahepatic cholestasis of pregnancy. Clin Sci (Lond) 2006 110 : 459 465.
26. Robey PG, Termine JD. Human bone cells in vitro. Calcif Tissue Int 1985 37 : 453 460.
27. Hernandez MV, Guañabens N, Alvarez L, Monegal A, Peris P, Riba J et al. Immunocytochemical evidence on the effects of glucocorticoids on type I collagen synthesis in human osteoblastic cells. Calcif Tissue Int 2004 74 : 284 293.
28. Livak KJ, Schmittgen TD. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001 25 : 402 408.
29. Aronow MA, Gerstenfeld LC, Owen TA, Tassinari MS, Stein GS, Lian JB. Factors that promote progressive development of the osteoblast phenotype in cultured fetal rat calvaria cells. J Cell Physiol 1990 143 : 213 221.
30. Pockwinse SM, Wilming LG, Conlon DM, Stein GS, Lian JB. Expression of cell growth and bone specific genes at single cell resolution during development of bone tissue-like organization in primary osteoblast cultures. J Cell Biochem 1992 49 : 310 323.
31. Stein GS, Lian JB. Molecular mechanisms mediating proliferation/differentiation interrelationships during progressive development of the osteoblast phenotype. Endocr Rev 1993 14 : 424 442.
32. Turksen K, Aubin JE. Positive and negative immunoselection for enrichment of two classes of osteoprogenitor cells. J Cell Biol 1991 114 : 373 384.
33. Rodan GA, Noda M. Gene expression in osteoblastic cells. Crit Rev Eukaryot Gene Expr 1991 1 : 85 98.
34. Ceryak S, Bouscarel B, Malavolti M, Fromm H. Extrahepatic deposition and cytotoxicity of lithocholic acid: studies in two hamster models of hepatic failure and in cultured human fibroblasts. Hepatology 1998 27 : 546 556.
35. Roda A, Cappelleri G, Aldini R, Roda E, Barbara L. Quantitative aspects of the interaction of bile acids with human serum albumin. J Lipid Res 1982 23 : 490 495.
36. Ceryak S, Bouscarel B, Fromm H. Comparative binding of bile acids to serum lipoproteins and albumin. J Lipid Res 1993 34 : 1661 1674.
37. Guañabens N, Parés A, Ros I, Caballería L, Pons F, Vidal S et al. Severity of cholestasis and advanced histological stage but not menopausal status are the major risk factors for osteoporosis in primary biliary cirrhosis. J Hepatol 2005 42 : 573 577.
38. Nagpal S, Na S, Rathhnachalam R. Noncalcemic actions of vitamin D receptor ligand. Endocr Rev 2005 26 : 662 687.
39. Haussler MR, Whitfield GK, Haussler CA, Hsieh JC, Thompson PD, Selznick SH et al. The nuclear vitamin D receptor: biological and molecular regulatory properties revealed. J Bone Miner Res 1998 13 : 325 349.
40. Aubin JE, Bonnelye E. Osteoprotegerin and its ligand: a new paradigm for regulation of osteoclastogenesis and bone resorption. Osteoporos Int 2000 11 : 905 913.
41. Kerner SA, Scott RA, Pike JW. Sequence elements in the human osteocalcin gene confer basal activation and inducible response to hormonal vitamin D3. Proc Natl Acad Sci USA 1989 86 : 4455 4459.
42. Tashiro K, Ishii C, Ryoji M. Role of distal upstream sequence in vitamin D-induced expression of human CYP24 gene. Biochem Biophys Res Commun 2007 358 : 259 265.
43. Tashiro K, Abe T, Oue N, Yasui W, Ryoji M. Characterization of vitamin D-mediated induction of the CYP 24 transcription. Mol Cell Endocrinol 2004 226 : 27 32.
44. Diamond TH, Stiel D, Lunzer M, McDowall D, Eckstein RP, Posen S. Hepatic osteodystrophy. Static and dynamic bone histomorphometry and serum bone Gla-protein in 80 patients with chronic liver disease. Gastroenterology 1989 96 : 213 221.
45. Dibble JB, Sheridan P, Losowsky MS. A survey of vitamin D deficiency in gastrointestinal and liver disorders. Q J Med 1984 53 : 119 134.
46. Stellon AJ, Webb A, Compston J, Williams R. Low bone turnover state in primary biliary cirrhosis. Hepatology 1987 7 : 137 142.